Measures facilitate approval of 48 first-in-class innovative drugs

News ESG Reports

Date: 20th Mar, 2025 Source: Ministry of Human Resources and Social Security Country: China Original Source

Brief

"On Tuesday, the National Medical Products Administration released a report stating that China approved 48 first-in-class innovative drugs. These medicines cover nearly 20 therapeutic areas, including oncology, neurological disorders, and anti-infective medicines, with 17 receiving market approval through a priority review pathway."

This content is restricted.

Highlights content goes here...

This content is restricted.

Ministry of Human Resources and Social Security

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Measures facilitate approval of 48 first-in-class innovative drugs

Brief

Ministry of Human Resources and Social Security

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Measures facilitate approval of 48 first-in-class innovative drugs

Brief

Ministry of Human Resources and Social Security

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.